[Recombinant alpha2-interferon substances in treating patients with acute hepatitis B with a mild course].
Interferon (viferon-500 and reaferon) is recommended for patients with light forms of acute virus hepatitis B to prevent chronic degeneration of the disease. The data of dynamic monitoring of the production of alpha-interferon helped develop a test for predicting threatened chronic degeneration of light forms of hepatitis B. Indications for antiviral therapy aimed at prevention of chronic disease have been defined.